Atlas Trials

Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT

Clinical trial NCT04738981 · COMPLETED

Trial details

NCT number
NCT04738981
Sponsor
Peking University People's Hospital
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Graft Vs Host Disease
Start date
2021-02-01
Primary completion
2022-05-30
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.